Literature DB >> 22424018

Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).

Harmony R Reynolds1, Sandra A Forman, Jacqueline E Tamis-Holland, Philippe Gabriel Steg, Daniel B Mark, Camille A Pearte, Antonio C Carvalho, George Sopko, Li Liu, Gervasio A Lamas, Mariusz Kruk, Krystyna Loboz-Grudzien, Witold Ruzyllo, Judith S Hochman.   

Abstract

BACKGROUND: Long-term follow-up (up to 9 years) from the OAT allows for the examination of sex differences in outcomes and the effect of percutaneous coronary intervention (PCI) in a relatively homogeneous cohort of myocardial infarction (MI) survivors.
METHODS: The OAT randomized 484 (22%) women and 1717 men to PCI of the occluded infarct-related artery vs medical therapy alone >24 hours post-MI. There was no benefit of PCI on the composite of death, MI, and class IV heart failure. We analyzed outcomes by sex and investigated for sex-based trial selection bias using a concurrent registry.
RESULTS: Women were older and more likely to have left anterior descending infarct-related artery, diabetes and hypertension, history of heart failure, and rales at randomization but were less likely to smoke. The proportion and characteristics of women enrolled in the trial and the registry were similar, including left ventricular ejection fraction and extent of disease. Women had higher rates of the primary composite (hazard ratio [HR] 1.48, P = .0002), death (HR 1.50, P = .001), and heart failure (HR 2.53, P < .0001) but not reinfarction (HR 1.12, P = .57). Female sex was not independently associated with the primary end point or death on multivariate analysis. There was a trend toward independent association of female sex with heart failure (HR 1.66, P = .02).
CONCLUSION: Women in OAT had a higher primary end point event rate than did men, mainly driven by heart failure. Female sex was not independently associated with death or MI in this well-defined cohort with comparable extent of coronary artery disease, similar medical therapy, and equivalent left ventricular ejection fraction by sex. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424018      PMCID: PMC3308117          DOI: 10.1016/j.ahj.2012.01.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  21 in total

1.  Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; A Patel; M Jones; C L Grines; S Ellis; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; F Ribichini; C Granger; F Akhras; W D Weaver; R J Simes
Journal:  Eur Heart J       Date:  2002-04       Impact factor: 29.983

2.  The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction.

Authors:  Marc Cohen; Gian Franco Gensini; Frans Maritz; Enrique P Gurfinkel; Kurt Huber; Ari Timerman; Jose Santopinto; Giancarlo Corsini; Pierfranco Terrosu; Florence Joulain
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

3.  Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry.

Authors:  C Maynard; P E Litwin; J S Martin; W D Weaver
Journal:  Arch Intern Med       Date:  1992-05

4.  Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry).

Authors:  Tobias Heer; Rudolf Schiele; Steffen Schneider; Anselm K Gitt; Harm Wienbergen; Martin Gottwik; Ulf Gieseler; Thomas Voigtländer; Karl E Hauptmann; Stefan Wagner; Jochen Senges
Journal:  Am J Cardiol       Date:  2002-03-01       Impact factor: 2.778

5.  Trends in acute myocardial infarction management: use of the National Registry ofMyocardial Infarction in quality improvement.

Authors:  W J French
Journal:  Am J Cardiol       Date:  2000-03-09       Impact factor: 2.778

6.  Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.

Authors:  Judith S Hochman; Harmony R Reynolds; Vladimír Dzavík; Christopher E Buller; Witold Ruzyllo; Zygmunt P Sadowski; Aldo P Maggioni; Antonio C Carvalho; James M Rankin; Harvey D White; Suzanne Goldberg; Sandra A Forman; Daniel B Mark; Gervasio A Lamas
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

7.  Sex differences in 2-year mortality after hospital discharge for myocardial infarction.

Authors:  V Vaccarino; H M Krumholz; J Yarzebski; J M Gore; R J Goldberg
Journal:  Ann Intern Med       Date:  2001-02-06       Impact factor: 25.391

8.  The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.

Authors:  James E Udelson; Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Joseph A Kufera; Sandra A Forman; Anna Teresinska; Bartosz Bychowiec; Jose Antonio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt P Sadowski; Witold Ruzyllo; Debra J Kinan; Gervasio A Lamas; Judith S Hochman
Journal:  Am Heart J       Date:  2011-03       Impact factor: 4.749

9.  Sex disparities in procedure use for acute myocardial infarction in the United States, 1995 to 2001.

Authors:  Alain G Bertoni; Denise E Bonds; James Lovato; David C Goff; Frederick L Brancati
Journal:  Am Heart J       Date:  2004-06       Impact factor: 4.749

10.  Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.

Authors:  W D Weaver; H D White; R G Wilcox; P E Aylward; D Morris; A Guerci; E M Ohman; G I Barbash; A Betriu; Z Sadowski; E J Topol; R M Califf
Journal:  JAMA       Date:  1996-03-13       Impact factor: 56.272

View more
  3 in total

Review 1.  Sex differences in long-term mortality after myocardial infarction: a systematic review.

Authors:  Emily M Bucholz; Neel M Butala; Saif S Rathore; Rachel P Dreyer; Alexandra J Lansky; Harlan M Krumholz
Journal:  Circulation       Date:  2014-07-22       Impact factor: 29.690

2.  In-hospital outcomes of delayed stenting in hemodynamically stable patients with ST-segment elevation myocardial infarction: the CCC (Care for Cardiovascular Disease in China) project.

Authors:  Jia-Wei Wu; Hao Hu; Dan Li; Li-Kun Ma
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

3.  The Value of CHA2DS2VASC Score in Predicting All-Cause Mortality in Patients with ST-Segment Elevation Myocardial Infarction Who Have Undergone Primary Percutaneous Coronary Intervention.

Authors:  Kudret Keskin; Süleyman Sezai Yıldız; Gökhan Çetinkal; Gökhan Aksan; Hakan Kilci; Şükrü Çetin; Serhat Sığırcı; Kadriye Kılıçkesmez
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.